Shilpa Medicare Limited (IN:SHILPAMED)
:SHILPAMED
Want to see IN:SHILPAMED full AI Analyst Report?
SHILPAMED Stock Chart & Stats
₹319.90
-₹8.10(-0.96%)
At close: 4:00 PM EST
₹319.90
-₹8.10(-0.96%)
Day’s Range― - ―
52-Week Range₹260.00 - ₹529.80
Previous CloseN/A
Volume218.26K
Average Volume (3M)38.83K
Market Cap
₹96.44B
Enterprise Value₹101.64B
Total Cash (Recent Filing)₹535.50M
Total Debt (Recent Filing)₹5.93B
Price to Earnings (P/E)35.2
Beta0.86
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)7.01
Shares Outstanding195,581,820
10 Day Avg. Volume85,780
30 Day Avg. Volume38,829
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)2.63
Price to Sales (P/S)4.43
P/FCF Ratio-90.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.95
Revenue Forecast (FY)₹16.94B
Bulls Say, Bears Say
Bulls Say
Healthy Balance Sheet / Low LeverageShilpa's materially lower debt-to-equity and strong equity ratio provide durable financial stability. Low leverage reduces refinancing risk, preserves capacity for strategic R&D and contract-manufacturing investments, and supports resilience through industry cycles over the next 2-6 months.
Robust Revenue Growth And Gross MarginsSustained top-line expansion with very high gross margins indicates strong product mix and pricing power in complex/specialty APIs and formulations. This durable margin cushion supports reinvestment into development and international sales, underpinning multi-month growth momentum.
Efficient Operating Cash GenerationOperating cash flows exceeding reported net income reflect effective cash conversion from core operations. This durable cash-generation ability helps fund working capital and operational needs, reducing near-term liquidity strain despite elevated capex requirements.
Bears Say
Negative Free Cash Flow Due To CapexSignificant capex has driven free cash flow negative, constraining internal funding for dividends, debt reduction or opportunistic investments. If elevated investment levels persist, the company may need external financing or to slow discretionary spending, affecting medium-term flexibility.
Falling Operating (EBIT) MarginA sharp drop in EBIT margin signals rising operating costs or unfavorable product mix that erodes the benefit of high gross margins. This structural efficiency deterioration weakens scalability and could pressure profits and reinvestment capacity over the coming months if not addressed.
Modest Returns On Equity & Net ProfitabilityDespite balance-sheet strength, low ROE and modest net margins limit shareholder returns and internal capital generation. Persistently low returns reduce the ability to fund growth from accruals and may constrain strategic initiatives without sustained margin improvement.
Shilpa Medicare Limited News
SHILPAMED FAQ
What was Shilpa Medicare Limited’s price range in the past 12 months?
Shilpa Medicare Limited lowest stock price was ₹260.00 and its highest was ₹529.80 in the past 12 months.
What is Shilpa Medicare Limited’s market cap?
Shilpa Medicare Limited’s market cap is ₹96.44B.
When is Shilpa Medicare Limited’s upcoming earnings report date?
Shilpa Medicare Limited’s upcoming earnings report date is Aug 06, 2026 which is in 72 days.
How were Shilpa Medicare Limited’s earnings last quarter?
Shilpa Medicare Limited released its earnings results on May 22, 2026. The company reported ₹3.3 earnings per share for the quarter, the consensus estimate of ₹3.3 by ₹0.
Is Shilpa Medicare Limited overvalued?
According to Wall Street analysts Shilpa Medicare Limited’s price is currently Overvalued.
Does Shilpa Medicare Limited pay dividends?
Shilpa Medicare Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.16%. See more information on Shilpa Medicare Limited dividends here
What is Shilpa Medicare Limited’s EPS estimate?
Shilpa Medicare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shilpa Medicare Limited have?
Shilpa Medicare Limited has 195,581,820 shares outstanding.
What happened to Shilpa Medicare Limited’s price movement after its last earnings report?
Shilpa Medicare Limited reported an EPS of ₹3.3 in its last earnings report, expectations of ₹3.3. Following the earnings report the stock price went up 3.778%.
Which hedge fund is a major shareholder of Shilpa Medicare Limited?
Currently, no hedge funds are holding shares in IN:SHILPAMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
Technical Analysis
Akums Drugs and Pharmaceuticals Limited
―
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Jubilant Pharmova Limited
―
Strides Pharma Science Ltd
―